Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holbrook E Kohrt

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|January 30, 2009
Optimizing therapy for acute myeloid leukemiaHolbrook E Kohrt, Steven E Coutre
Academic Medicine : Journal of the Association of American Medical Colleges|January 26, 2012
What happened to the concept of the physician-scientist?Matthew J Goldstein, Holbrook E Kohrt
Frontiers in Immunology|December 24, 2015
Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer ImmunotherapyCariad Chester, Katherine Fritsch, Holbrook E Kohrt
European Journal of Cancer (Oxford, England : 1990)|January 12, 2016
Rationale for anti-CD137 cancer immunotherapyAmani Makkouk, Cariad Chester, Holbrook E Kohrt
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2015
Scientific Significance of Clinically Insignificant FcγRIIIa-V158F PolymorphismGuillaume Cartron, Roch Houot, Holbrook E Kohrt
Cancer Immunology, Immunotherapy : CII|April 2, 2016
4-1BB agonism: adding the accelerator to cancer immunotherapyCariad Chester, Siddhant Ambulkar, Holbrook E Kohrt
Journal for Immunotherapy of Cancer|November 19, 2015
A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trialAmabel Cl Tan, Anne Goubier, Holbrook E Kohrt
British Journal of Haematology|February 15, 2011
Acute myeloid leukaemia in the elderly: a reviewDaniel A Pollyea, Holbrook E Kohrt, Bruno C Medeiros
Vaccine|September 23, 2015
Critical issues in cancer vaccine trial designGuy T Clifton, Holbrook E Kohrt, George E Peoples
Chinese Clinical Oncology|March 3, 2016
Harnessing the innate immune system to treat cancer: enhancement of antibody-dependent cellular cytotoxicity with anti-CD137 AbAtsushi Yonezawa, Cariad Chester, Narendiran Rajasekaran, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Journal of the National Comprehensive Cancer Network : JNCCN|January 30, 2009
Optimizing therapy for acute myeloid leukemiaHolbrook E Kohrt, Steven E Coutre
Academic Medicine : Journal of the Association of American Medical Colleges|January 26, 2012
What happened to the concept of the physician-scientist?Matthew J Goldstein, Holbrook E Kohrt
Frontiers in Immunology|December 24, 2015
Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer ImmunotherapyCariad Chester, Katherine Fritsch, Holbrook E Kohrt
European Journal of Cancer (Oxford, England : 1990)|January 12, 2016
Rationale for anti-CD137 cancer immunotherapyAmani Makkouk, Cariad Chester, Holbrook E Kohrt
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2015
Scientific Significance of Clinically Insignificant FcγRIIIa-V158F PolymorphismGuillaume Cartron, Roch Houot, Holbrook E Kohrt
Cancer Immunology, Immunotherapy : CII|April 2, 2016
4-1BB agonism: adding the accelerator to cancer immunotherapyCariad Chester, Siddhant Ambulkar, Holbrook E Kohrt
Journal for Immunotherapy of Cancer|November 19, 2015
A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trialAmabel Cl Tan, Anne Goubier, Holbrook E Kohrt
British Journal of Haematology|February 15, 2011
Acute myeloid leukaemia in the elderly: a reviewDaniel A Pollyea, Holbrook E Kohrt, Bruno C Medeiros
Vaccine|September 23, 2015
Critical issues in cancer vaccine trial designGuy T Clifton, Holbrook E Kohrt, George E Peoples
Chinese Clinical Oncology|March 3, 2016
Harnessing the innate immune system to treat cancer: enhancement of antibody-dependent cellular cytotoxicity with anti-CD137 AbAtsushi Yonezawa, Cariad Chester, Narendiran Rajasekaran, et al.
Pageof 7